I'm The King of Business & Technology in the Modern World

Matthew Borja stood by the floor-to-ceiling window of his office, his hands resting in his pockets as he gazed at the Manila skyline. The city sprawled beneath him—chaotic, alive, and full of untapped potential. But for all its movement, its energy, the country was still decades behind in certain industries.

That was about to change.

He turned away from the window, grabbing his phone and sending Angel a quick message.

Matthew: "Meet me in my office. Now."

A few minutes later, the door swung open, and Angel walked in, tablet in hand, already sensing the weight of the conversation that was about to unfold.

"You never text like that unless it's something big," she said, raising an eyebrow. "What's on your mind?"

Matthew gestured for her to sit. "I'm starting a new subsidiary."

Angel blinked. "Another one? We just expanded Sentinel AI, and we're still integrating our new telecom division. What's this about?"

He sat across from her, fingers interlocked. "Bioengineering. Specifically, exoskeleton technology."

Angel stared at him for a moment before letting out a small laugh. "You're serious."

"Dead serious."

Her amusement faded. "That's… ambitious. Even for you."

"Not just ambitious," Matthew corrected. "It's necessary. The way I see it, exoskeletons are inevitable. They'll redefine how people work, how soldiers fight, how industries operate. Right now, the technology is primitive—bulky, inefficient, nowhere near commercial viability. But if we get ahead of this, if we become the first company to mass-produce exoskeletons at an affordable scale, we won't just be leading the industry… we'll create it."

Angel nodded slowly, processing his words. "And you're thinking military applications?"

"That's part of it," Matthew admitted. "But we start civilian. Industrial-grade exoskeletons first—construction, mining, heavy logistics. There's already a demand for that. Companies are investing in ergonomic solutions to prevent worker injuries. A properly designed exosuit could double or even triple efficiency in labor-intensive industries."

Angel pursed her lips. "That makes sense. No immediate regulatory hurdles if we go industrial first. But even then, exoskeletons are expensive to manufacture. Advanced materials, power sources, neural interfaces… It's not like building another software company."

"I know," Matthew said. "That's why I'm setting up an entirely new subsidiary—Sentinel BioTech."

Angel exhaled. "Alright. So let's talk challenges."

She pulled up her tablet, already compiling notes. "First problem—materials. Exoskeletons need to be lightweight but durable. Current designs use aluminum alloys or basic carbon fiber, but that's not enough for true military or industrial use. You'll need something stronger."

"I'm looking into graphene-reinforced titanium," Matthew said. "It's theoretical now, but it's the future. We'll invest in materials science startups already working on advanced composites."

Angel nodded. "That leads to the second issue—engineering talent. We're talking about robotics, biomechanics, AI integration, and neural interfaces. Those specialists aren't exactly easy to find."

"We won't find them here," Matthew admitted. "I'll recruit internationally—Japan, Germany, the U.S. Some of the best minds in bioengineering are out there, working on prosthetics and neural research. We need to poach them."

Angel tilted her head. "Which means… what? Setting up research hubs outside the Philippines?"

"Exactly. We'll establish Sentinel BioTech's primary R&D facility in Singapore. Strong government support for tech, access to global talent, and no bureaucratic headaches."

Angel typed something on her tablet before pausing. "Alright, let's talk money. R&D costs alone will be massive. Prototyping? Manufacturing? We're looking at a multi-billion-dollar investment just to get to the testing phase."

Matthew smirked. "Which is why I'm not using Sentinel Systems' funding for this."

Angel raised an eyebrow. "Then where's the money coming from?"

"I'll secure private investors. Quiet backers—people who understand the value of this technology but don't want their names attached until it succeeds."

Angel frowned. "You mean… defense contractors?"

Matthew nodded. "Some of them, yes. But also venture capitalists in Silicon Valley, sovereign wealth funds, and a few industrial heavyweights who want a stake in the next big technological shift."

Angel hesitated. "You do realize that once word gets out, governments will start watching us. This isn't like software, Matthew. This is weapons-grade technology."

"I know," he said. "And that's why we control the narrative. We position Sentinel BioTech as a civilian-focused company. Exosuits for workers, medical applications for paraplegics. We develop the technology under that premise—and once we've perfected it, then we explore military applications."

Angel rubbed her forehead. "You've already thought this through."

Matthew leaned forward. "Angel, this is bigger than just another tech business. This is about controlling the future of human augmentation. If we master exoskeletons, we'll be the first company to push humans beyond their natural limits."

She exhaled. "Fine. So what do you need from me?"

Matthew smirked. "Everything. We're setting up Sentinel BioTech immediately."

Phase One: Laying the Groundwork

Angel nodded, pulling up a list of actionable steps.

Corporate Structuring

Register Sentinel BioTech as a separate LLC under Sentinel Systems

Secure legal teams specializing in biotech regulations

Establish an offshore holding company in Singapore to attract foreign investors

R&D and Recruitment

Begin headhunting engineers, AI specialists, materials scientists

Acquire startups already working on biomechanics, neurotech, and advanced composites

Identify research institutions for potential partnerships

Funding Strategy

Secure $2 billion in initial investment from silent backers

Structure funding through a mix of equity and strategic partnerships

Approach Silicon Valley VCs, sovereign wealth funds, and industrial giants

Manufacturing & Infrastructure

Scout locations for a high-tech prototyping facility

Invest in cutting-edge fabrication technologies for advanced materials

Secure partnerships with component suppliers

Angel looked up from her screen. "This is going to be the most expensive venture you've ever launched."

Matthew smirked. "And it's going to be the most profitable."

She exhaled. "Alright. I'll start making calls. But we're going to need a public announcement at some point."

"Not yet," Matthew said. "We keep this quiet until we're ready."

Angel stood, glancing at him. "You know, most people in your position would be taking it easy after what just happened with Vargas."

Matthew chuckled. "That's exactly why I'm doing this now. While they're still recovering from the last fight, I'm already moving on to the next battlefield."

Angel shook her head, a grin forming. "You're impossible."

Matthew smirked. "I'm inevitable."

As she left the office, Matthew leaned back in his chair, staring at his laptop screen once more.

Sentinel BioTech was no longer just an idea.

It was real.

And soon, the world would feel its impact.